Identification of Naturally Processed HLA-A2—Restricted Proinsulin Epitopes by Reverse Immunology
- Yousra Hassainya1,
- Francisco Garcia-Pons2,
- Roland Kratzer1,
- Vivian Lindo3,
- Fiona Greer3,
- François A. Lemonnier2,
- Gabriele Niedermann4 and
- Peter M. van Endert1
- 1Institut National de la Santé et de la Recherche Médicale Unité 580, Université René Descartes, Paris, France
- 2Unité d’Immunité Cellulaire Antivirale, Département d’Immunologie, Institut Pasteur, Paris, France
- 3M-SCAN, Wokingham, U.K
- 4Department of Cellular Immunology, Max Planck Institute of Immunobiology, Freiburg, Germany
- Address correspondence and reprint requests to Dr, Peter van Endert, INSERM U580, Hôpital Necker, 161 rue de Sèvres, 75743 Paris, Cedex 15, France. E-mail: vanendert{at}necker.fr
Abstract
Type 1 diabetes is thought to result from the destruction of β-cells by autoantigen-specific T-cells. Observations in the NOD mouse model suggest that CD8+ cytotoxic T-cells play an essential role in both the initial triggering of insulitis and its destructive phase. However, little is known about the epitopes derived from human β-cell autoantigens and presented by HLA class I molecules. We used a novel reverse immunology approach to identify HLA-A2−restricted, naturally processed epitopes derived from proinsulin, an autoantigen likely to play an important role in the pathogenesis of type 1 diabetes. Recombinant human proinsulin was digested with purified proteasome complexes to establish an inventory of potential COOH-terminals of HLA class I−presented epitopes. Cleavage data were then combined with epitope predictions based on the SYFPEITHI and BIMAS algorithms to select 10 candidate epitopes; 7 of these, including 3 with a sequence identical to murine proinsulin, were immunogenic in HLA-A2 transgenic mice. Moreover, six of six tested peptides were processed and presented by proinsulin-expressing cells. These results demonstrate the power of reverse immunology approaches. Moreover, the novel epitopes may be of significant interest in monitoring autoreactive T-cells in type 1 diabetes.
- CTL, cytotoxic T-cell
- MHC, major histocompatibility complex
- TAP, transporter associated with antigen processing
Footnotes
-
- Accepted April 12, 2005.
- Received December 23, 2004.
- DIABETES














